Dignio

The company's core business revolves around its connected care platform, which enables healthcare providers such as hospitals and municipalities to create virtual wards and monitor patients remotely. This model is designed to increase efficiency for healthcare services, reduce hospital admissions, and improve the quality of life for patients. Dignio's revenue is generated through the provision of these technology solutions to healthcare organizations. As of December 2020, the company had secured contracts with nearly 200 municipalities in Norway. Financially, the company has shown significant growth, with revenues reported at NOK 24 million in 2019 and a projection of NOK 45 million for 2020. A major funding milestone was a Series A round in December 2020, which raised NOK 85 million (approximately $9.6M) from investors including Investinor, Funkybiz, and Monte Rosa Capital, fueling its international expansion.

Dignio's primary offering is the Dignio Prevent software platform, which integrates with the patient-facing application, MyDignio. Patients use the app on a tablet or smartphone, along with various connected medical devices, to perform daily health assessments. The platform allows for monitoring vital signs, medication compliance, and self-reporting of symptoms. This data is transmitted in real-time to healthcare professionals who can intervene if measurements fall outside predefined thresholds. Key features include a health diary, symptom tracker, video consultations, and messaging, supporting patients with conditions like COPD, diabetes, heart failure, and hypertension. The platform is hardware-agnostic, integrating with over 20 medical devices, and also supports medication management through smart pillboxes like Pilly. In August 2022, Dignio acquired AceAge, further enhancing its capabilities.